These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
901 related articles for article (PubMed ID: 9973505)
1. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. Xia Y; Vetvicka V; Yan J; Hanikýrová M; Mayadas T; Ross GD J Immunol; 1999 Feb; 162(4):2281-90. PubMed ID: 9973505 [TBL] [Abstract][Full Text] [Related]
2. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). Thornton BP; Vĕtvicka V; Pitman M; Goldman RC; Ross GD J Immunol; 1996 Feb; 156(3):1235-46. PubMed ID: 8558003 [TBL] [Abstract][Full Text] [Related]
3. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568 [TBL] [Abstract][Full Text] [Related]
4. Generation of recombinant fragments of CD11b expressing the functional beta-glucan-binding lectin site of CR3 (CD11b/CD18). Xia Y; Ross GD J Immunol; 1999 Jun; 162(12):7285-93. PubMed ID: 10358177 [TBL] [Abstract][Full Text] [Related]
5. Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. Vetvicka V; Thornton BP; Ross GD J Clin Invest; 1996 Jul; 98(1):50-61. PubMed ID: 8690804 [TBL] [Abstract][Full Text] [Related]
6. Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18). Vetvicka V; Thornton BP; Wieman TJ; Ross GD J Immunol; 1997 Jul; 159(2):599-605. PubMed ID: 9218574 [TBL] [Abstract][Full Text] [Related]
7. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Hong F; Hansen RD; Yan J; Allendorf DJ; Baran JT; Ostroff GR; Ross GD Cancer Res; 2003 Dec; 63(24):9023-31. PubMed ID: 14695221 [TBL] [Abstract][Full Text] [Related]
8. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. Ross GD; Cain JA; Lachmann PJ J Immunol; 1985 May; 134(5):3307-15. PubMed ID: 2984286 [TBL] [Abstract][Full Text] [Related]
9. Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18). Roubey RA; Ross GD; Merrill JT; Walton F; Reed W; Winchester RJ; Buyon JP J Immunol; 1991 May; 146(10):3557-62. PubMed ID: 1673986 [TBL] [Abstract][Full Text] [Related]
10. Dissimilar and similar functional properties of complement receptor-3 in microglia and macrophages in combating yeast pathogens by phagocytosis. Hadas S; Reichert F; Rotshenker S Glia; 2010 May; 58(7):823-30. PubMed ID: 20091776 [TBL] [Abstract][Full Text] [Related]
11. Requirement of leukocytic cell adhesion molecules (CD11a-c/CD18) in the enhanced NK lysis of iC3b-opsonized targets. Ramos OF; Patarroyo M; Yefenof E; Klein E J Immunol; 1989 Jun; 142(11):4100-4. PubMed ID: 2565929 [TBL] [Abstract][Full Text] [Related]
12. Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan. Yan J; Vetvicka V; Xia Y; Hanikýrová M; Mayadas TN; Ross GD Immunopharmacology; 2000 Jan; 46(1):39-54. PubMed ID: 10665778 [TBL] [Abstract][Full Text] [Related]
13. CD11b/CD18 integrin and a beta-glucan receptor act in concert to induce the synthesis of platelet-activating factor by monocytes. Elstad MR; Parker CJ; Cowley FS; Wilcox LA; McIntyre TM; Prescott SM; Zimmerman GA J Immunol; 1994 Jan; 152(1):220-30. PubMed ID: 7902855 [TBL] [Abstract][Full Text] [Related]
14. The function of human NK cells is enhanced by beta-glucan, a ligand of CR3 (CD11b/CD18). Di Renzo L; Yefenof E; Klein E Eur J Immunol; 1991 Jul; 21(7):1755-8. PubMed ID: 2060581 [TBL] [Abstract][Full Text] [Related]
15. Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/alphaMbeta2-integrin glycoprotein. Ross GD Crit Rev Immunol; 2000; 20(3):197-222. PubMed ID: 10968371 [TBL] [Abstract][Full Text] [Related]
16. Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules. Vĕtvicka V; Hanikýrová M; Vĕtvicková J; Ross GD Clin Exp Immunol; 1999 Feb; 115(2):229-35. PubMed ID: 9933447 [TBL] [Abstract][Full Text] [Related]
17. Complement receptor 3, not Dectin-1, is the major receptor on human neutrophils for beta-glucan-bearing particles. van Bruggen R; Drewniak A; Jansen M; van Houdt M; Roos D; Chapel H; Verhoeven AJ; Kuijpers TW Mol Immunol; 2009 Dec; 47(2-3):575-81. PubMed ID: 19811837 [TBL] [Abstract][Full Text] [Related]
18. Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors. Galon J; Gauchat JF; Mazières N; Spagnoli R; Storkus W; Lötze M; Bonnefoy JY; Fridman WH; Sautès C J Immunol; 1996 Aug; 157(3):1184-92. PubMed ID: 8757624 [TBL] [Abstract][Full Text] [Related]
19. Evidence for involvement of beta-glucan-binding cell surface lectins in human natural killer cell function. Duan X; Ackerly M; Vivier E; Anderson P Cell Immunol; 1994 Sep; 157(2):393-402. PubMed ID: 8069924 [TBL] [Abstract][Full Text] [Related]
20. Cocapping of the leukoadhesin molecules complement receptor type 3 and lymphocyte function-associated antigen-1 with Fc gamma receptor III on human neutrophils. Possible role of lectin-like interactions. Zhou M; Todd RF; van de Winkel JG; Petty HR J Immunol; 1993 Apr; 150(7):3030-41. PubMed ID: 7681086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]